Alcarraz-Vizán G - Search Results

1

Epicatechin gallate impairs colon cancer cell metabolic productivity.

Sánchez-Tena S, Alcarraz-Vizán G, Marín S, Torres JL, Cascante M. Sánchez-Tena S, et al. J Agric Food Chem. 2013 May 8;61(18):4310-7. doi: 10.1021/jf3052785. Epub 2013 Apr 29. J Agric Food Chem. 2013. PMID: 23594085

2

Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets.

Vizán P, Sánchez-Tena S, Alcarraz-Vizán G, Soler M, Messeguer R, Pujol MD, Lee WN, Cascante M. Vizán P, et al. Carcinogenesis. 2009 Jun;30(6):946-52. doi: 10.1093/carcin/bgp083. Epub 2009 Apr 15. Carcinogenesis. 2009. PMID: 19369582

3

Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study.

Alcarraz-Vizán G, Sánchez-Tena S, Moyer MP, Cascante M. Alcarraz-Vizán G, et al. Biochim Biophys Acta. 2014 Jun;1840(6):1634-9. doi: 10.1016/j.bbagen.2013.12.024. Epub 2013 Dec 22. Biochim Biophys Acta. 2014. PMID: 24368265

4

Quantification of intracellular phosphorylated carbohydrates in HT29 human colon adenocarcinoma cell line using liquid chromatography-electrospray ionization tandem mass spectrometry.

Vizán P, Alcarraz-Vizán G, Díaz-Moralli S, Rodríguez-Prados JC, Zanuy M, Centelles JJ, Jáuregui O, Cascante M. Vizán P, et al. Anal Chem. 2007 Jul 1;79(13):5000-5. doi: 10.1021/ac070170v. Epub 2007 May 25. Anal Chem. 2007. PMID: 17523595

5

Modulation of pentose phosphate pathway during cell cycle progression in human colon adenocarcinoma cell line HT29.

Vizán P, Alcarraz-Vizán G, Díaz-Moralli S, Solovjeva ON, Frederiks WM, Cascante M. Vizán P, et al. Int J Cancer. 2009 Jun 15;124(12):2789-96. doi: 10.1002/ijc.24262. Int J Cancer. 2009. PMID: 19253370 Free article.

6

A lyophilized red grape pomace containing proanthocyanidin-rich dietary fiber induces genetic and metabolic alterations in colon mucosa of female C57BL/6J mice.

Lizarraga D, Vinardell MP, Noé V, van Delft JH, Alcarraz-Vizán G, van Breda SG, Staal Y, Günther UL, Carrigan JB, Reed MA, Ciudad CJ, Torres JL, Cascante M. Lizarraga D, et al. J Nutr. 2011 Sep;141(9):1597-604. doi: 10.3945/jn.110.133199. Epub 2011 Jul 20. J Nutr. 2011. PMID: 21775529 Free article.

7

Diphenyl urea derivatives as inhibitors of transketolase: a structure-based virtual screening.

Obiol-Pardo C, Alcarraz-Vizán G, Cascante M, Rubio-Martinez J. Obiol-Pardo C, et al. PLoS One. 2012;7(3):e32276. doi: 10.1371/journal.pone.0032276. Epub 2012 Mar 5. PLoS One. 2012. PMID: 22403640 Free PMC article.

8

Design of an interface peptide as new inhibitor of human glucose-6-phosphate dehydrogenase.

Obiol-Pardo C, Alcarraz-Vizán G, Díaz-Moralli S, Cascante M, Rubio-Martinez J. Obiol-Pardo C, et al. J Mol Graph Model. 2014 Apr;49:110-7. doi: 10.1016/j.jmgm.2014.02.004. Epub 2014 Feb 28. J Mol Graph Model. 2014. PMID: 24637073

9

Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation.

Alcarraz-Vizán G, Boren J, Lee WN, Cascante M. Alcarraz-Vizán G, et al. Metabolomics. 2010 Jun;6(2):229-237. doi: 10.1007/s11306-009-0192-0. Epub 2010 Jan 8. Metabolomics. 2010. PMID: 20445757 Free PMC article.

10

BACE2 suppression in mice aggravates the adverse metabolic consequences of an obesogenic diet.

Díaz-Catalán D, Alcarraz-Vizán G, Castaño C, de Pablo S, Rodríguez-Comas J, Fernández-Pérez A, Vallejo M, Ramírez S, Claret M, Parrizas M, Novials A, Servitja JM. Díaz-Catalán D, et al. Among authors: alcarraz vizan g. Mol Metab. 2021 Nov;53:101251. doi: 10.1016/j.molmet.2021.101251. Epub 2021 May 17. Mol Metab. 2021. PMID: 34015524 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page